|
The Cochrane Collaboration
Cochrane Reviews |
| Explore | New + Updated | Other languages |
|
|
|
Corticosteroids for viral myocarditisChen H, Liu J, Yang M SummaryCorticosteroids may be effective in treating people with viral myocarditisViral infection occasionally triggers myocarditis (inflammation and necrosis of the heart muscle) which can result in severe, acute heart failure. The first signs of this condition may be flu-like symptoms which evolve into non-specific chest discomfort, shortness of breath or palpitations. The majority of patients recover spontaneously but others have continuing heart problems which require medication and can be severe enough to cause death. Corticosteroids may suppress the inflammatory immune response to viral infection and improve outcomes but their use remains controversial. The review authors made a thorough search of the medical literature. No randomised trials which met the inclusion criteria compared corticosteroids with placebo, supportive therapy, antiviral therapy or conventional therapy, including trials of corticosteroids plus other treatment versus other treatment alone, for viral myocarditis.
This is a Cochrane review abstract and plain language summary, prepared and maintained by The Cochrane Collaboration, currently published in The Cochrane Database of Systematic Reviews 2008 Issue 3, Copyright © 2008 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd.. The full text of the review is available in The Cochrane Library (ISSN 1464-780X).
This version first published online:
October 18. 2006 AbstractBackgroundMyocarditis is an uncommon heart disease. There is experimental evidence showing that autoimmune mechanisms follow viral infection, resulting in inflammation and necrosis in myocardium. However, the use of corticosteroids as immunosuppressives in this condition remains controversial. ObjectivesTo assess the beneficial and harmful effects of treating viral myocarditis with corticosteroids. Search strategyTrials were identified by searching The Cochrane Heart Group Register ( to April 2004), the Cochrane Library (Issue 4, 2003), and MEDLINE, EMBASE, BIOSIS for meeting abstracts, LILACS, and Chinese Biomedical CD Database from their date of inception to April 20, 2004. Four Chinese medical journals were handsearched. A total of 507 articles were found but none of them was eligible to be included in our review. Selection criteriaRandomised controlled trials of corticosteroids for viral myocarditis compared with no intervention, placebo, supportive therapy, antiviral agents therapy or conventional therapy, including trials of corticosteroids plus other treatment versus other treatment alone, irrespective of blinding, publication status, or language. Data collection and analysisTwo reviewers extracted data independently. We asked authors of trials to provide information when diagnosis or methodology was unclear or data were incomplete. Results were presented as risk ratios (RR) and weighted mean differences (WMD), both with 95% confidence intervals (CI). Main resultsNo randomised controlled trials of corticosteroids for viral myocarditis were found that met our inclusion criteria. Authors' conclusionsThere is no randomised evidence to support the use of corticosteroids for viral myocarditis. Further clinical trials are needed. |